Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:32 pm Purchase | 2026-03-31 | 13G | ABEONA THERAPEUTICS INC NE ABEO | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 3,333,757 5.820% | 715,295 (+27.32%) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 148,736 3.388% | -40,969 (-21.60%) | Filing History |
| 2026-04-07 4:32 pm Purchase | 2026-03-31 | 13G | CURIS INC PAR $0.01 CRIS | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2,944,000 6.978% | 2,944,000 (New Position) | Filing History |
| 2025-11-14 4:31 pm Purchase | 2025-09-30 | 13G | INSPIREMD INC NSPR | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2,418,016 5.676% | 1,006,380 (+71.29%) | Filing History |
| 2025-11-14 4:20 pm Purchase | 2025-09-30 | 13G | DARIOHEALTH CORP COM PAR 0.000 DRIO | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 316,497 4.591% | 190,941 (+152.08%) | Filing History |
| 2025-10-06 4:31 pm Purchase | 2025-09-29 | 13G | ABEONA THERAPEUTICS INC NE ABEO | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2,618,462 5.090% | 2,618,462 (New Position) | Filing History |
| 2025-08-14 4:36 pm Purchase | 2025-08-08 | 13G | KIORA PHARMACEUTICALS INC KPRX | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 189,705 5.299% | 189,705 (New Position) | Filing History |
| 2025-05-15 4:43 pm Purchase | 2025-03-31 | 13G | SENTI BIOSCIENCES INC SNTI | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 502,500 1.900% | 201,000 (+66.67%) | Filing History |
| 2025-05-15 4:42 pm Sale | 2025-03-31 | 13G | SURROZEN INC SRZN | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 73,918 2.200% | -103,052 (-58.23%) | Filing History |
| 2025-03-06 4:31 pm Purchase | 2025-02-27 | 13G | DARIOHEALTH CORP COM DRIO | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 125,556 5.777% | 125,556 (New Position) | Filing History |
| 2025-02-19 4:32 pm Purchase | 2025-02-16 | 13G | EAGLE PHARMACEUTICALS INC EGRX | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 810,630 6.241% | 810,630 (New Position) | Filing History |
| 2025-02-14 4:31 pm Purchase | 2024-12-02 | 13G | SENTI BIOSCIENCES INC SNTI | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 301,500 5.914% | 301,500 (New Position) | Filing History |
| 2024-12-20 4:31 pm Sale | 2024-12-19 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 300,902 2.760% | -487,882 (-61.85%) | Filing History |
| 2024-12-04 4:31 pm Purchase | 2024-11-27 | 13G | INSPIREMD INC NSPR | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1,411,636 5.220% | 1,411,636 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | SURROZEN INC SRZN | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 176,970 5.280% | 176,970 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 788,784 7.760% | 576,609 (+271.76%) | Filing History |
| 2024-02-02 8:32 pm Purchase | 2023-09-29 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 212,175 6.100% | 212,175 (New Position) | Filing History |